Gösta Gahrton

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: HAEMATOLOGICA. 2024
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study.
Niederwieser D; Hasenclever D; Berdel WE; Biemond BJ; Al-Ali H; Chalandon Y; Van Gelder M; Junghanß C; Gahrton G; Hänel M; Hehlmann R; Heinicke T; Hochhaus A; Iacobelli S; Kooy RVM; Kröger N; Janssen J; Jentzsch M; Breywisch F; Mohty M; Masouridi-Levrat S; Ossenkoppele G; Passweg J; Pönisch W; Schetelig J; Schliemann C; Schwind S; Stelljes M; Verdonck LF; Vucinic V; Löwenberg B; Cornelissen J
Article: CANCER MEDICINE. 2023;12(22):20736-20744
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma
Nahi H; Afram G; Uttervall K; Lockmer S; Tatting L; Gahrton G; Kashif M; Alici E; Stromberg O; Klimkowska M; Lund J
Journal article: HEMATOLOGY JOURNAL. 2023
CAR-T cell treatment of high-risk multiple myeloma – will there be a cure?
Gahrton G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):749-754
Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care
Afram G; Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2022;28(5):258.e1-258.e8
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment
Reinoso-Segura M; Caballero-Velazquez T; Herrera P; Patriarca F; Fanin R; Bruno B; Einsele H; Nahi H; Granell M; Lopez-Corral L; Reguera JL; Garcia-Cadenas I; Gahrton G; Perez-Simon JA
Article: CELL REPORTS MEDICINE. 2022;3(2):100508
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
Nahi H; Chrobok M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Blomberg P; Holmqvist P-H; Walther-Jallow L; Mellstrom K; Liwing J; Gustafsson C; Mansson R; Klimkowska M; Gahrton G; Lund J; Ljungman P; Ljunggren H-G; Alici E
Article: BLOOD CANCER JOURNAL. 2021;11(12):192
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Fernandez de Larrea C; Kyle R; Rosinol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; San Miguel J; Blade J; Rajkumar SV; Victoria Mateos M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(4):546-554
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups
Afram G; Susek KH; Uttervall K; Wersall JD; Wagner AK; Luong V; Lund J; Gahrton G; Alici E; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2020;55(9):1810-1816
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation
Costa LJ; Iacobelli S; Pasquini MC; Modi R; Giaccone L; Blade J; Schonland S; Evangelista A; Perez-Simon JA; Hari P; Brown EE; Giralt SA; Patriarca F; Stadtmauer EA; Rosinol L; Krishnan AY; Gahrton G; Bruno B
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(6):588-596
Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?
Gran C; Uttervall K; Bruchfeld JB; Wallblom A; Alici E; Gahrton G; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(3):247-254
Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma
Uttervall K; Bruchfeld JB; Gran C; Walinder G; Mansson R; Lund J; Gahrton G; Alici E; Nahi H
Article: PLOS ONE. 2019;14(2):e0211927
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
Nahi H; Chrobok M; Gran C; Lund J; Gruber A; Gahrton G; Ljungman P; Wagner AK; Alici E
Journal article: BLOOD. 2018;132(Supplement 1):3464
Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT
Gran C; Wang J; Nahi H; Koster L; Gahrton G; Wolschke C; Einsele H; Itälä-Remes M; Blaise D; Niederwieser D; Meijer E; Petersen EJ; de Wreede LC; Ljungman P; Bourhis J-H; Veelken H; Beelen DW; Stelljes M; Gerbitz A; Ceballos P; Finke J; Passweg JR; Milpied N-J; Bornhäuser M; Yakoub-Agha I; Schönland S; Garderet L; Kroeger N
Article: CANCER MEDICINE. 2018;7(6):2256-2268
Lenalidomide versus lenalidomide plus dexamethasone prolonged treatment after second-line lenalidomide plus dexamethasone induction in multiple myeloma
Lund J; Gruber A; Lauri B; Duru AD; Blimark C; Swedin A; Hansson M; Forsberg K; Ahlberg L; Carlsson C; Waage A; Gimsing P; Vangsted AJ; Frolund U; Holmberg E; Gahrton G; Alici E; Hardling M; Mellqvist U-H; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(4):386-388
Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients
Gran C; Gahrton G; Alici E; Nahi H
Article: LEUKEMIA & LYMPHOMA. 2017;58(4):797-808
Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting
Garderet L; Cook G; Auner HW; Bruno B; Lokhorst H; Antonio Perez-Simon J; Sahebi F; Scheid C; Morris C; van Biezen A; Sobh M; Michallet M; Gahrton G; Schoenland S; Kroeger N
Article: LEUKEMIA. 2016;30(10):2047-2054
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party
Sobh M; Michallet M; Gahrton G; Iacobelli S; van Biezen A; Schoenland S; Petersen E; Schaap N; Bonifazi F; Volin L; Meijer E; Niederwieser D; El-Cheikh J; Tabrizi R; Fegeux N; Finke J; Bunjes D; Cornelissen J; Einsele H; Bruno B; Potter M; Fanin R; Mohty M; Garderet L; Kroeger N
Article: ANNALS OF HEMATOLOGY. 2016;95(6):967-972
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study
Gratwohl A; Iacobelli S; Bootsman N; van Biezen A; Baldomero H; Arcese W; Arnold R; Bron D; Cordonnier C; Ernst P; Ferrant A; Frassoni F; Gahrton G; Richard C; Kolb HJ; Link H; Niederwieser D; Ruutu T; Schattenberg A; Schmitz N; Torres-Gomez A; Zwaan F; Apperley J; Olavarria E; Kroeger N
Article: LEUKEMIA & LYMPHOMA. 2016;57(1):183-192
A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells
Cardona ME; Simonson OE; Oprea II; Moreno PMD; Silva-Lara MF; Mohamed AJ; Christensson B; Gahrton G; Dilber MS; Smith CIE; Arteaga HJ
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;96(1):46-54
Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21
Nahi H; Vatsveen TK; Lund J; Heeg BMS; Preiss B; Alici E; Moller MB; Wader KF; Moller HEH; Groseth LA; Ostergaard B; Dai HY; Holmberg E; Gahrton G; Waage A; Abildgaard N
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(12):2039-2051
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; Miguel JS; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):808-812
Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT
Grovdal M; Nahi H; Gahrton G; Liwing J; Waage A; Abildgaard N; Pedersen PT; Hammerstrom J; Laaksonen A; Bazia P; Terava V; Ollikainen H; Silvennoinen R; Putkonen M; Anttila P; Porkka K; Remes K
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):802-807
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
Sahebi F; Iacobelli S; Biezen AV; Volin L; Dreger P; Michallet M; Ljungman PT; de Witte T; Henseler A; Schaap NPM; Lopez-Corral L; Poire X; Passweg J; Hamljadi R-M; Thomas SH; Schonland S; Gahrton G; Morris C; Kroeger N; Garderet L
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(6):1054-1058
Efficacy and Outcome of Allogeneic Transplantation in IgD and Nonsecretory Myeloma. A Report on Behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
Morris C; Iacobelli S; Gahrton G; van Biezen A; Drake M; Garderet L; Potter M; Schattenberg AV; Cornelissen JJ; Hamladji R-M; Martelli M; Petersen E; Rovira M; Bandini G; Kroger N; de Witte T
Article: BONE MARROW TRANSPLANTATION. 2015;50(4):505-510
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial
Iacobelli S; de Wreede LC; Schoenland S; Bjorkstrand B; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Carella AM; Beksac M; Bosi A; Milone G; Corradini P; Friberg K; van Biezen A; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Garderet L; Kroeger N; Gahrton G
Article: PLOS ONE. 2015;10(9):e0138248
Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma
Duru AD; Sutlu T; Wallblom A; Uttervall K; Lund J; Stellan B; Gahrton G; Nahi H; Alici E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2014;164(5):684-693
Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population
Liwing J; Uttervall K; Lund J; Aldrin A; Blimark C; Carlson K; Enestig J; Flogegard M; Forsberg K; Gruber A; Kviele HH; Johansson P; Lauri B; Mellqvist U-H; Swedin A; Svensson M; Nasman P; Alici E; Gahrton G; Aschan J; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2014;92(1):19-25
Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma - a retrospective population based study of 1162 patients
Lund J; Uttervall K; Liwing J; Gahrton G; Alici E; Aschan J; Holmberg E; Nahi H
Article: PLOS ONE. 2014;9(7):e101819
The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment
Uttervall K; Duru AD; Lund J; Liwing J; Gahrton G; Holmberg E; Aschan J; Alici E; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2013;48(11):1395-1400
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation
Auner HW; Szydlo R; van Biezen A; Iacobelli S; Gahrton G; Milpied N; Volin L; Janssen J; Quoc SN; Michallet M; Schoemans H; el Cheikh J; Petersen E; Guilhot F; Schoenland S; Ahlberg L; Morris C; Garderet L; de Witte T; Kroeger N
Article: BLOOD. 2013;121(25):5055-5063
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study
Gahrton G; Iacobelli S; Bjorkstrand B; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Carella AM; Beksac M; Bosi A; Milone G; Corradini P; Schoenland S; Friberg K; van Biezen A; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Garderet L; Kroeger N
Article: LEUKEMIA. 2012;26(1):149-157
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Kumar SK; Lee JH; Lahuerta JJ; Morgan G; Richardson PG; Crowley J; Haessler J; Feather J; Hoering A; Moreau P; LeLeu X; Hulin C; Klein SK; Sonneveld P; Siegel D; Blade J; Goldschmidt H; Jagannath S; Miguel JS; Orlowski R; Palumbo A; Sezer O; Rajkumar SV; Durie BGM
Article: LAKARTIDNINGEN. 2011;108(45):2261
[Palliative care. Allow active euthanasia when there is no hope of cure].
Gahrton G
Article: BLOOD. 2011;118(12):3205-3211
Approach to the treatment of multiple myeloma: a clash of philosophies
Rajkumar SV; Gahrton G; Bergsagel PL
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(22):3016-3022
Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up
Bjorkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G
Article: BLOOD. 2011;117(23):6063-6073
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Cavo M; Rajkumar SV; Palumbo A; Moreau P; Orlowski R; Bladé J; Sezer O; Ludwig H; Dimopoulos MA; Attal M; Sonneveld P; Boccadoro M; Anderson KC; Richardson PG; Bensinger W; Johnsen HE; Kroeger N; Gahrton G; Bergsagel PL; Vesole DH; Einsele H; Jagannath S; Niesvizky R; Durie BGM; San Miguel J; Lonial S; International Myeloma Working Group
Article: BLOOD. 2011;117(18):4691-4695
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Rajkumar SV; Harousseau J-L; Durie B; Anderson KC; Dimopoulos M; Kyle R; Blade J; Richardson P; Orlowski R; Siegel D; Jagannath S; Facon T; Avet-Loiseau H; Lonial S; Palumbo A; Zonder J; Ludwig H; Vesole D; Sezer O; Munshi NC; San Miguel J; International Myeloma Workshop Consensus Panel 1
Article: RECENT RESULTS IN CANCER RESEARCH. 2011;183:273-284
Allogeneic transplantation in multiple myeloma.
Gahrton G
Article: HAEMATOLOGICA. 2010;95(12):2126-2133
Efficacy and outcome of autologous transplantation in rare myelomas
Morris C; Drake M; Apperley J; Iacobelli S; van Biezen A; Bjorkstrand B; Goldschmidt H; Harousseau J-L; Morgan G; de Witte T; Niederwieser D; Gahrton G
Article: CYTOTHERAPY. 2010;12(8):1044-1055
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
Sutlu T; Stellan B; Gilljam M; Quezada HC; Nahi H; Gahrton G; Alici E
Article: LEUKEMIA RESEARCH. 2010;34(12):1627-1629
Constitutional inv(3) in myelodysplastic syndromes
Gahrton C; Nahi H; Jansson M; Wallblom A; Alici E; Sutlu T; Samuelsson J; Gahrton G
Article: HUMAN GENE THERAPY. 2010;21(8):929-941
TK.007: A Novel, Codon-Optimized HSVtk(A168H) Mutant for Suicide Gene Therapy
Preuss E; Treschow A; Newrzela S; Bruecher D; Weber K; Felldin U; Alici E; Gahrton G; von Laer D; Dilber MS; Fehse B
Article: HAEMATOLOGICA. 2010;95(5):804-809
Primary plasma cell leukemia and autologous stem cell transplantation
Drake MB; Iacobelli S; van Biezen A; Morris C; Apperley JF; Niederwieser D; Bjorkstrand B; Gahrton G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;148(2):323-331
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation
Kroeger N; Shimoni A; Schilling G; Schwerdtfeger R; Bornhaueser M; Nagler A; Zander AR; Heinzelmann M; Brand R; Gahrton G; Morris C; Niederwieser D; de Witte T
Article: LEUKEMIA. 2009;23(10):1904-1912
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Kumar S; Munshi NC; Dispenzieri A; Kyle R; Merlini G; San Miguel J; Ludwig H; Hajek R; Jagannath S; Blade J; Lonial S; Dimopoulos MA; Einsele H; Barlogie B; Anderson KC; Gertz M; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Richardson PG; Niesvizky R; Rajkumar SV; Durie BGM; IMWG
Article: ONCOLOGY REPORTS. 2009;22(1):137-142
Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation
Paul E; Sutlu T; Deneberg S; Alici E; Bjorkstrand B; Jansson M; Lerner R; Wallblom A; Gahrton G; Nahi H
Article: BLOOD. 2008;111(6):3155-3162
Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
Alici E; Sutlu T; Boejrkstrand B; Gilljam M; Stellan B; Nahi H; Quezada HC; Gahrton G; Ljunggren H-G; Dilber MS
Article: EXPERIMENTAL HEMATOLOGY. 2007;35(12):1839-1846
Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model
Alici E; Konstantinidis KV; Sutlu T; Aints A; Gahrton G; Ljunggren H-G; Dilber MS
Article: HAEMATOLOGICA. 2007;92(11):1513-1518
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma
Gahrton G; Iacobelli S; Bandini G; Bjorkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kroeger N; Schattenberg A; Schoenland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D
Article: SEMINARS IN HEMATOLOGY. 2007;44(4):227-233
High-dose treatment with autologous stem cell transplantation in multiple myeloma:: Past, present, and future
Björkstrand B; Gahrton G
Article: HAEMATOLOGICA. 2007;92(8):1083-1090
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+cell selection: long term follow-up of an EBMT phase III randomized study
Bourhis J-H; Bouko Y; Koscielny S; Bakkus M; Greinix H; Derigs G; Salles G; Feremans W; Apperley J; Samson D; Bjoerkstrand B; Niederwieser D; Gahrton G; Pico J-L; Goldschmidt H
Article: BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. 2007;20(2):219-229
Risk assessment in haematopoietic stem cell transplantation: Impact of donor-recipient sex combination in allogeneic transplantation
Gahrton G
Article: BLOOD. 2007;109(8):3588-3594
Reduced-intensity conditioning for myeloma:: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning
Crawley C; Iacobelli S; Bjorkstrand B; Apperley JF; Niederwieser D; Gahrton G
Article: CANCER GENE THERAPY. 2007;14(3):227-232
Long-term follow-up of gene-marked CD34⁺ cells after autologous stem cell transplantation for multiple myeloma
Alici E; Bjorkstrand B; Treschow A; Aints A; Smith CIE; Gahrton G; Dilber MS
Article: LEUKEMIA. 2006;20(9):1467-1473
International uniform response criteria for multiple myeloma
Durie BGM; Harousseau J-L; Miguel JS; Blade J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV
Article: LEUKEMIA & LYMPHOMA. 2006;47(9):1768-1773
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase
Olsson-Stromberg U; Hoglund M; Bjorkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Lofvenberg E; Malm C; Nilsson P-G; Paul C; Rodjer S; Stenke L; Tidefeldt U; Turesson I; Uden A-M; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
Article: CLINICAL ADVANCES IN HEMATOLOGY AND ONCOLOGY. 2006;4(5):388-391
Pro: allogeneic transplantation in multiple myeloma.
Gahrton G
Article: BLOOD. 2006;107(6):2578-2584
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis:: a report from the European Group for Blood and Marrow Transplantation
Schönland SP; Lokhorst H; Buzyn A; Leblond V; Hegenbart U; Bandini G; Campbell A; Carreras E; Ferrant A; Grommisch L; Jacobs P; Kröger N; La Nasa G; Russell N; Zachee P; Goldschmidt H; Lacobelli S; Niederwieser D; Gahrton G
Article: CURRENT OPINION IN HEMATOLOGY. 2005;12(6):463-470
Progress in hematopoietic stem cell transplantation in multiple myeloma.
Gahrton G
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;62(5):429-436
Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokines
Arteaga HJ; Mohamed AJ; Christensson B; Mahdy E; Gahrton G; Smith CIE; Dilber MS
Article: EXPERIMENTAL HEMATOLOGY. 2005;33(8):883-893
Identification of progression markers in B-CLL by gene expression profiling
Fält S; Merup M; Gahrton G; Lambert B; Wennborg A
Article: BLOOD. 2005;106(2):681-689
Distinctive gene expression pattern in V_H3-21 utilizing B-cell chronic lymphocytic leukemia
Fält S; Merup M; Tobin G; Thunberg U; Gahrton G; Rosenquist R; Wennborg A
Article: BLOOD. 2005;105(11):4532-4539
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma:: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
Crawley C; Lalancette M; Szydlo R; Gilleece M; Peggs K; Mackinnon S; Juliusson G; Ahlberg L; Nagler A; Shimoni A; Sureda A; Boiron JM; Einsele H; Chopra R; Carella A; Cavenagh J; Gratwohl A; Garban F; Zander A; Björkstrand B; Niederwieser D; Gahrton G; Apperley JF
Article: BONE MARROW TRANSPLANTATION. 2005;35(6):609-617
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma:: reduced relapse risk in female to male transplants
Gahrton G; Iacobelli S; Apperley J; Bandini G; Björkstrand B; Bladé J; Boiron JM; Cavo M; Cornelissen J; Corradini P; Kröger N; Ljungman P; Michallet M; Russell NH; Samson D; Schattenberg A; Sirohi B; Verdonck LF; Volin L; Zander A; Niederwieser D
Article: BONE MARROW TRANSPLANTATION. 2005;35(1):37-43
Stem cell transplantation from identical twins in patients with myelodysplastic syndromes.
Kröger N; Brand R; van Biezen A; Bron D; Blaise D; Hellström-Lindberg E; Gahrton G; Powles R; Littlewood T; Chapuis B; Zander A; Koza V; Niederwieser D; de Witte T; Myelodysplastic Syndromes Subcommittee of the Chro
Article: ACTA HAEMATOLOGICA. 2005;113(3):155-162
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia:: Long-term follow-up
Simonsson B; Öberg G; Björeman M; Björkholm M; Carneskog J; Karlsson K; Gahrton G; Grimfors G; Hast R; Karle H; Linder O; Ljungman P; Nielsen JL; Nilsson J; Löfvenberg E; Malm C; Olsson K; Olsson-Strömberg U; Paul C; Stenke L; Stentoft J; Turesson I; Udén AM; Wahlin A; Vilén L; Weis-Bjerrum O
Article: HUMAN MOLECULAR GENETICS. 2004;13(23):2925-2936
Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemia
Hammarsund M; Lerner M; Zhu CY; Merup M; Jansson M; Gahrton G; Kluin-Nelemans H; Einhorn S; Grandér D; Sangfelt O; Corcoran M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(9):1674-1681
Benefit and timing of second transplantations in multiple myeloma: Clinical findings and methodological limitations in a European group for blood and marrow transplantation registry study
Morris C; Iacobelli S; Brand R; Bjorkstrand B; Drake M; Niederwieser D; Gahrton G
Article: HEMATOLOGY JOURNAL. 2004;5(6):462-466
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia:: BMT prolongs survival
Olsson-Strömberg U; Simonsson B; Ahlgren T; Björkholm M; Carlsson K; Gahrton G; Hast R; Löfvenberg E; Linder O; Ljungman P; Malm C; Paul C; Rödjer S; Turesson I; Udén AM; Wahlin A; Killander A; Wadman B; Westin J; Vikrot O; Zettervall O; Öberg G
Article: BLOOD. 2003;102(5):1927-1929
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.
Corradini P; Cavo M; Lokhorst H; Martinelli G; Terragna C; Majolino I; Valagussa P; Boccadoro M; Samson D; Bacigalupo A; Russell N; Montefusco V; Voena C; Gahrton G; Chronic Leukemia Working Party of the European Gro
Article: LEUKEMIA. 2003;17(9):1827-1833
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes:: better outcome in patients with less proliferative disease
Hast R; Hellström-Lindberg E; Ohm L; Björkholm M; Celsing F; Dahl JM; Dybedal I; Gahrton G; Lindberg G; Lerner R; Linder O; Löfvenberg E; Nilsson-Ehle H; Paul C; Samuelsson J; Tangen JM; Tidefelt U; Turesson I; Wahlin A; Wallvik J; Winquist I; Öberg G; Bernell P
Article: BONE MARROW TRANSPLANTATION. 2003;32(2):121-124
The World Marrow Donor Association (WMDA): its goals and activities
Gahrton G; van Rood JJ; Oudshoorn M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2003;121(5):749-757
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders:: a report of the International Myeloma Working Group
Kyle RA; Child JA; Anderson K; Barlogie B; Bataille R; Bensinger W; Bladé J; Boccadoro M; Dalton W; Dimopoulos M; Djulbegovic B; Drayson M; Durie B; Facon T; Fonseca R; Gahrton G; Greipp P; Harousseau JL; Harrington D; Hussein M; Joshua D; Ludwig H; Morgan G; Oken M; Powles R; Richardson P; Roodman D; San Miguel J; Shimizu K; Shustik C; Sirohi B; Sonneveld P; Tricot G; Turesson I; Van Ness B; Vesole D; Weber D; Westin J; Wheatley K
Article: HUMAN GENE THERAPY. 2002;13(17):2085-2110
Opinion paper on the current status of the regulation of gene therapy in Europe
Cohen-Haguenauer O; Rosenthal F; Gänsbacher B; Bolhuis R; Dorsch-Häsler KD; Eshhar Z; Gahrton G; Hokland P; Melani C; Rankin E; Thielemans K; Vile R; Zwierzina H; Cichutek K
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2002;68(6):376-381
Long-term follow-up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapy
Öberg G; Killander A; Björeman M; Gahrton G; Grimfors G; Gruber A; Hast R; Lerner R; Liliemark J; Mattson S; Paul C; Simonsson B; Stalfelt AM; Stenke L; Tidefelt U; Udén AM; Björkholm M
Article: GENE THERAPY. 2001;8(14):1051-1056
Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting
Aints A; Güven H; Gahrton G; Smith CIE; Dilber MS
Article: CYTOKINE. 2001;14(3):136-142
Expression and release of stable and active forms of murine granulocyte-macrphage colony-stimulating factor (mGM-CSF) targeted to different subcellular compartments
Arteaga HJ; Mohamed AJ; Christensson B; Gahrton G; Smith CIE; Dilber MS
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2001;67(1):20-26
Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells
Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CIE; Dilber MS
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;113(1):209-216
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.
Gahrton G; Svensson H; Cavo M; Apperly J; Bacigalupo A; Björkstrand B; Bladé J; Cornelissen J; de Laurenzi A; Facon T; Ljungman P; Michallet M; Niederwieser D; Powles R; Reiffers J; Russell NH; Samson D; Schaefer UW; Schattenberg A; Tura S; Verdonck LF; Vernant JP; Willemze R; Volin L; European Group for Blood and Marrow Transplantatio
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):511-515
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma:: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)
Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Mandelli F; Marcus R; Boogaerts M; Alegre A; Remes K; Cornelissen JJ; Bladé J; Lenhoff S; Iriondo A; Carlson K; Volin L; Littlewood T; Goldstone AH; San Miguel J; Schattenberg A; Gahrton G
Article: GENOMICS. 2000;70(3):327-334
Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14
Kapanadze B; Makeeva N; Corcoran M; Jareborg N; Hammarsund M; Baranova A; Zabarovsky E; Vorontsova O; Merup M; Gahrton G; Jansson M; Yankovsky N; Einhorn S; Oscier D; Grandér D; Sangfelt O
Article: LEUKEMIA. 2000;14(1):112-118
Mutagen exposures and chromosome 3 aberrations in acute myelocytic leukemia
Lindquist R; Forsblom AM; Öst A; Gahrton G
Article: BONE MARROW TRANSPLANTATION. 1999;24(7):741-745
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.
Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J
Article: GENOMICS. 1999;60(2):161-171
Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates
Wu XS; Ivanova G; Merup M; Jansson M; Stellan B; Grandér D; Zabarovsky E; Gahrton G; Einhorn S
Article: PATHOLOGIE ET BIOLOGIE. 1999;47(2):188-191
Allogeneic bone marrow transplantation in multiple myeloma
Gahrton G
Article: AMERICAN JOURNAL OF PATHOLOGY. 1998;153(6):1923-1935
Lipoprotein receptors in acute myelogenous leukemia -: Failure to defect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation
Rudling M; Gåfvels M; Parini P; Gahrton G; Angelin B
Article: LANCET. 1998;352(9134):1087-1092
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Gratwohl A; Hermans J; Goldman JM; Arcese W; Carreras E; Devergie A; Frassoni F; Gahrton G; Kolb HJ; Niederwieser D; Ruutu T; Vernant JP; de Witte T; Apperley J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1998;102(5):1115-1123
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.
Bladé J; Samson D; Reece D; Apperley J; Björkstrand B; Gahrton G; Gertz M; Giralt S; Jagannath S; Vesole D
Article: LEUKEMIA. 1998;12(5):705-709
A FISH cosmid 'cocktail' for detection of 13q deletions in chronic lymphocytic leukaemia - comparison with cytogenetics and Southern hybridization
Merup M; Jansson M; Corcoran M; Liu Y; Wu X; Rasool OZ; Stellan B; Hermansson M; Juliusson G; Gahrton G; Einhorn S
Article: BLOOD. 1998;91(9):3397-3400
6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas
Merup M; Moreno TC; Heyman M; Rönnberg K; Grandér D; Detlofsson R; Rasool O; Liu Y; Söderhäll S; Juliusson G; Gahrton G; Einhorn S
Article: ANTICANCER RESEARCH. 1998;18(2A):759-767
Production of a motility factor by a newly established lung adenocarcinoma cell line
Klominek J; Robért KH; Bergh J; Hjerpe A; Gahrton G; Sundqvist KG
Article: BLOOD. 1998;91(4):1382-1390
Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia
Corcoran MM; Rasool O; Liu Y; Iyengar A; Grander D; Ibbotson RE; Merup M; Wu XS; Brodyansky V; Gardiner AC; Juliusson G; Chapman RM; Ivanova G; Tiller M; Gahrton G; Yankovsky N; Zabarovsky E; Oscier DG; Einhorn S
Article: LEUKEMIA. 1997;11(12):2105-2110
Increased frequency of chromosome abnormalities in fibroblasts from hairy cell leukemia patients.
Haglund U; Stellan B; Juliusson G; Gahrton G
Article: GENES CHROMOSOMES & CANCER. 1997;20(4):337-346
Characterization of a hairy cell leukemia-associated 5q13.3 inversion breakpoint
Wu XS; Merup M; Juliusson G; Jansson M; Stellan B; Grander D; Zabarovsky E; Liu Y; Spasokoukotskaja T; Gahrton G; Einhorn S
Article: ONCOGENE. 1997;15(20):2463-2473
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia
Liu Y; Corcoran M; Rasool O; Ivanova G; Ibbotson R; Grander D; Iyengar A; Baranova A; Kashuba V; Merup M; Wu XS; Gardiner A; Mullenbach R; Poltaraus A; Hultstrom AL; Juliusson G; Chapman R; Tiller M; Cotter F; Gahrton G; Yankovsky N; Zabarovsky E; Einhorn S; Oscier D
Article: BONE MARROW TRANSPLANTATION. 1997;20(7):553-560
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
Article: CANCER RESEARCH. 1997;57(8):1523-1528
Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo
Dilber MS; Abedi MR; Christensson B; Bjorkstrand B; Kidder GM; Naus CCG; Gahrton G; Smith CIE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1997;58(3):174-180
Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia
Merup M; Juliusson G; Xu XH; Jansson M; Stellan B; Rasool O; Roijer E; Stenman G; Gahrton G; Einhorn S
Article: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 1997;11(1):147-157
Allogeneic stem cell transplantation for multiple myeloma
Bensinger WI; Buckner CD; Gahrton G
Article: BLOOD. 1996;88(12):4711-4718
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European group for blood and marrow transplantation
Bjorkstrand B; Ljungman P; Svensson H; Hermans J; Alegre A; Apperley J; Blade J; Carlson K; Cavo M; Ferrant A; Goldstone AH; deLaurenzi A; Majolino I; Marcus R; Prentice HG; Remes K; Samson D; Sureda A; Verdonck LF; Volin L; Gahrton G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;95(3):494-500
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J; van Biezen A; Arcese W; Debusscher L; Ernst P; Ferrant A; Frassoni F; Gahrton G; Iriondo A; Kolb HJ; Link H; Niederwieser D; Ruutu T; Siegert W; Zwaan FE
Article: BLOOD. 1996;88(6):2192-2200
Suicide gene therapy for plasma cell tumors
Dilber MS; Abedi MR; Bjorkstrand B; Christensson B; Gahrton G; Xanthopoulos KG; Smith CIE
Article: EUROPEAN JOURNAL OF CANCER. 1996;32A(8):1300-1302
Cancer research in the European community - Report from a meeting in Stockholm in 1995
Gahrton G; Graessmann A; Meunier F; Schmitt M; VanDongen JJM; Baig SS
Article: BONE MARROW TRANSPLANTATION. 1996;17(5):759-762
Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma: a pilot study of the EBMT.
Samson D; Volin L; Schanz U; Bosi A; Gahrtron G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(3):647-652
Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia
Merup M; Spasokoukotskaja T; Einhorn S; Smith CIE; Gahrton G; Juliusson G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(2):251-254
Allogeneic bone marrow transplantation in multiple myeloma.
Gahrton G
Article: ANNALS OF INTERNAL MEDICINE. 1996;124(3):311-315
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia
Michallet M; Archimbaud E; Bandini G; Rowlings PA; Deeg HJ; Gahrton G; Montserrat E; Rozman C; Gratwohl A; Gale RP
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(1):35-43
Indications for haemopoietic precursor cell transplants in Europe
Gratwohl A; Hermans J; Baldomero H; Tichelli A; Goldman JM; Gahrton G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(5):302-306
RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN BONE-MARROW STROMAL CELLS - STUDIES OF EFFICIENCY AND IN-VIVO SURVIVAL IN SCID MICE
LI KJ; DILBER MS; ABEDI MR; BJORKSTRAND B; SMITH CIE; GAROFF H; GAHRTON G; XANTHOPOULOS KG
Article: BLOOD. 1995;86(5):1911-1915
13Q DELETIONS IN LYMPHOID MALIGNANCIES
LIU Y; HERMANSON M; GRANDER D; MERUP M; WU XS; HEYMAN M; RASOOL O; JULIUSSON G; GAHRTON G; DETLOFSSON R; NIKIFOROVA N; BUYS C; SODERHALL S; YANKOVSKY N; ZABAROVSKY E; EINHORN S
Article: BLOOD. 1995;86(4):1614-1618
LONG-TERM EFFECTS OF HEPATITIS-C VIRUS-INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
LJUNGMAN P; JOHANSSON N; ASCHAN J; GLAUMANN H; LONNQVIST B; RINGDEN O; SPARRELID E; SONNERBORG A; WINIARSKI J; GAHRTON G
Article: STEM CELLS. 1995;13 Suppl 2:122-125
An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.
Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J
Article: STEM CELLS. 1995;13:140-146
AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF THE EUROPEAN GROUP FOR BONE-MARROW TRANSPLANTATION
BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; BRANDT L; ALEGRE A; AUZANNEAU G; BLADE J; BRUNET S; CARLSON K; CAVO M; FERRANT A; GRAVETT P; DELAURENZI A; PRENTICE HG; PROCTOR S; REMES K; TROUSSARD X; VERDONCK LF; WILLIAMS C; GAHRTON G
Article: BLOOD. 1995;86(2):813-818
Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation.
Gratwohl A; Hermans J; Apperley J; Arcese W; Bacigalupo A; Bandini G; di Bartolomeo P; Boogaerts M; Bosi A; Carreras E
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(1):19-23
MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON
BJORKHOLM M; LILIEMARK J; GAHRTON G; GRIMFORS G; GRUBER A; HAST R; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; LJUNGMAN P; LONNQVIST B; PALMBLAD J; PAUL C; PETTERSON C; SIMONSSON B; STALFELT AM; STENKE L; SUNDSTROM C; TIDEFELT U; UDEN AM; OBERG G; OST A
Article: JOURNAL OF CLINICAL ONCOLOGY. 1995;13(6):1312-1322
Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.
Gahrton G; Tura S; Ljungman P; Bladé J; Brandt L; Cavo M; Façon T; Gratwohl A; Hagenbeek A; Jacobs P
Article: BONE MARROW TRANSPLANTATION. 1995;15(4):619-625
SIMILAR INCIDENCE OF GRAFT-VERSUS-HOST DISEASE USING HLA-A, HLA-B AND HLA-DR IDENTICAL UNRELATED BONE-MARROW DONORS AS WITH HLA-IDENTICAL SIBLINGS
RINGDEN O; REMBERGER M; PERSSON U; LJUNGMAN P; ALDENER A; ANDSTROM E; ASCHAN J; BOLME P; DAHLLOF G; DALIANIS T; GAHRTON G; HAGGLUND H; LONNQVIST B; OLERUP O; SHANWELL A; SPARRELID E; WINIARSKI J; MOLLER E; OBERG M
Article: LAKARTIDNINGEN. 1995;92(9):849-853
[High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support].
Ljungman P; Björkstrand B; Gahrton G; Nordenström J; Shanwell A; Glas U; Rotstein S; Rutqvist LE; Wilking N
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):367-371
DOUBLE HIGH-DOSE CHEMORADIOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION CAN INDUCE MOLECULAR REMISSIONS IN MULTIPLE-MYELOMA
BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; GAHRTON G
Visa fler

Alla övriga publikationer

Review: LANCET ONCOLOGY. 2024;25(5):e205-e216
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
Rodriguez-Otero P; Usmani S; Cohen AD; van de Donk NWCJ; Leleu X; Gállego Pérez-Larraya J; Manier S; Nooka AK; Mateos MV; Einsele H; Minnema M; Cavo M; Derman BA; Puig N; Gay F; Ho PJ; Chng W-J; Kastritis E; Gahrton G; Weisel K; Nagarajan C; Schjesvold F; Mikhael J; Costa L; Raje NS; Zamagni E; Hájek R; Weinhold N; Yong K; Ye JC; Sidhana S; Merlini G; Martin T; Lin Y; Chari A; Popat R; Kaufman JL; International Myeloma Working Group
Editorial comment: HAEMATOLOGICA. 2023;108(10):2568-2569
CAR T-cell treatment of high-risk multiple myeloma: will there be a cure?
Gahrton G
Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(2):224-225
Response to Caravita di Toritto and Rago
Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H; Afram G
Conference publication: BLOOD. 2022;140:2126-2129
Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study
Niederwieser D; Hasenclever D; Berdel WE; Biemond BJ; Al-Ali HK; Chalandon Y; Van Gelder M; Junghanss C; Gahrton G; Haenel M; Hehlmann R; Heinicke T; Hochhaus A; Iacobelli S; Kooy RVM; Kroger N; Janssen JJWM; Jentzsch M; Breywisch F; Mohty M; Masouridi-Levrat S; Ossenkoppele G; Passweg J; Poenisch W; Schetelig J; Schliemann C; Schwind S; Stelljes M; Valk PJM; Lowenberg B; Cornelissen JJ
Meeting abstract: BLOOD. 2021;138:4796
CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion
Nahi H; Chrobook M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Walther-Jallow L; Liwing J; Klimkowska M; Gahrton G; Ljungman P; Ljunggren H-G; Alici E
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2021;194(3):496-507
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Rosinol L; Beksac M; Zamagni E; Van de Donk NWCJ; Anderson KC; Badros A; Caers J; Cavo M; Dimopoulos M-A; Dispenzieri A; Einsele H; Engelhardt M; Fernandez de Larrea C; Gahrton G; Gay F; Hajek R; Hungria V; Jurczyszyn A; Kroeger N; Kyle RA; Leal da Costa F; Leleu X; Lentzsch S; Mateos MV; Merlini G; Mohty M; Moreau P; Rasche L; Reece D; Sezer O; Sonneveld P; Usmani SZ; Vanderkerken K; Vesole DH; Waage A; Zweegman S; Richardson PG; Blade J
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(9):1559-1566
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT
Garderet L; Morris C; Beksac M; Gahrton G; Schoenland S; Yakoub-Agha I; Hayden PJ
Review: JOURNAL OF CLINICAL MEDICINE. 2020;9(7):E2180-2180
Allogeneic Transplantation in Multiple Myeloma-Does It Still Have a Place?
Gahrton G; Iacobelli S; Garderet L; Yakoub-Agha I; Schoenland S
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(5):e213-e217
Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT
Gran C; Wang J; Nahi H; Koster L; Gahrton G; Einsele H; Niittyvoupio R; Edinger M; Beelen D; Ciceri F; Bornhaeuser M; Finke J; de Wreede LC; Ljungman P; Mielke S; Tischer J; Garderet L; Schoenland S; Yakoub-Agha I; Kroeger N
Conference publication: BLOOD. 2019;134:259
Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up
Costa LJ; Iacobelli S; Pasquini MC; Modi R; Giaccone L; Blade J; Schonland S; Evangelista A; Perez-Simon JA; Hari P; Brown EE; Giralt SA; Patriarca F; Stadtmauer EA; Rosinol L; Krishnan AY; Gahrton G; Bruno B
Meeting abstract: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2019;19(10):E206
Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma - Improved Overall Survival in first line Hematopoietic Stem Cell Transplantation
Gran C; Wang J; Nahi H; Koster L; Gahrton G; Wolschke C; Einsele H; Niittyvoupio R; Blaise D; Niederwieser D; Meier E; Petersen E; de Wreede LC; Ljungman P; Bourhis JH; Veelken H; Beelen D; Stelljes M; Gerbitz A; Vincent L; Finke J; Passweg J; Milpied N; Stoelzel F; Yakoub-Agha I; Schoenland S; Garderet L; Kroger N
Meeting abstract: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2019;19(10):E170
Novel RNA construct increases cytotoxic proteins in lymphocytes and leads to prolonged survival in an experimental syngeneic immunocompetent Multiple Myeloma model
Wagner AK; Baloch AH; Chrobok M; Dahlberg C; Gahrton G; Nahi H; Ljunggren H-G; Alici E
Editorial comment: LANCET HAEMATOLOGY. 2017;4(6):e250-e251
Gemcitabine, busulfan, and melphalan conditioning for autologous stem-cell transplants in multiple myeloma
Gahrton G
Review: LEUKEMIA & LYMPHOMA. 2016;57(6):1256-1268
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)
Bruno B; Auner HW; Gahrton G; Garderet L; Festuccia M; Ladetto M; Lemoli RM; Massaia M; Morris C; Palumbo A; Schoenland S; Boccadoro M; Kroeger N
Review: LEUKEMIA. 2016;30(5):1005-1017
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
Laubach J; Garderet L; Mahindra A; Gahrton G; Caers J; Sezer O; Voorhees P; Leleu X; Johnsen HE; Streetly M; Jurczyszyn A; Ludwig H; Mellqvist U-H; Chng W-J; Pilarski L; Einsele H; Hou J; Turesson I; Zamagni E; Chim CS; Mazumder A; Westin J; Lu J; Reiman T; Kristinsson S; Joshua D; Roussel M; O'Gorman P; Terpos E; McCarthy P; Dimopoulos M; Moreau P; Orlowski RZ; Miguel JS; Anderson KC; Palumbo A; Kumar S; Rajkumar V; Durie B; Richardson PG
Review: LEUKEMIA. 2014;28(2):269-277
IMWG consensus on risk stratification in multiple myeloma
Chng WJ; Dispenzieri A; Chim C-S; Fonseca R; Goldschmidt H; Lentzsch S; Munshi N; Palumbo A; Miguel JS; Sonneveld P; Cavo M; Usmani S; Durie BGM; Avet-Loiseau H
Review: EXPERT REVIEW OF HEMATOLOGY. 2014;7(1):79-90
Allogeneic transplantation in multiple myeloma
Gahrton G; Krishnan A
Meeting abstract: BLOOD. 2013;122(21):920
Reduced Intensity Allogeneic Stem Cell Transplant In Patients With Multiple Myeloma: A Comparison Of Planned Autologous-Reduced Intensity Allogeneic Stem Cell Transplant (Auto-Allo) and Reduced Intensity Allogeneic Stem Cell Transplant (RIC) As Upfront Transplant In Patients With Multiple Myeloma, An EBMT Analysis
Sahebi F; Iacobelli S; Van Biezen A; Volin L; Dreger P; Michallet M; Ljungman PT; Gahrton G; Morris CTCM; Schonland S; de Witte T; Garderet L; Kroeger N; Henseler A; Schaap NPM; Caballero D; Poire X; Passweg J; Hamljadi R-M
Review: LEUKEMIA. 2013;27(4):780-791
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Fernandez de Larrea C; Kyle RA; Durie BGM; Ludwig H; Usmani S; Vesole DH; Hajek R; San Miguel JF; Sezer O; Sonneveld P; Kumar SK; Mahindra A; Comenzo R; Palumbo A; Mazumber A; Anderson KC; Richardson PG; Badros AZ; Caers J; Cavo M; Leleu X; Dimopoulos MA; Chim CS; Schots R; Noeul A; Fantl D; Mellqvist U-H; Landgren O; Chanan-Khan A; Moreau P; Fonseca R; Merlini G; Lahuerta JJ; Blade J; Orlowski RZ; Shah JJ
Letter: MEDICAL ONCOLOGY. 2013;30(2):569
In search of the molecular consequences of 8p21 deletion in multiple myeloma: commentary on Gmidene et al
Sutlu T; Alici E; Gahrton G; Nahi H
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(20):2475-2482
Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Garderet L; Iacobelli S; Moreau P; Dib M; Lafon I; Niederwieser D; Masszi T; Fontan J; Michallet M; Gratwohl A; Milone G; Doyen C; Pegourie B; Hajek R; Casassus P; Kolb B; Chaleteix C; Hertenstein B; Onida F; Ludwig H; Ketterer N; Koenecke C; van Os M; Mohty M; Cakana A; Gorin NC; de Witte T; Harousseau JL; Morris C; Gahrton G
Letter: CANCER GENETICS. 2012;205(6):338-339
Historical note on the discovery of the Philadelphia chromosome
Gahrton G
Other: MOLECULAR THERAPY. 2012;20(6):1084-1094
Challenges in Vector and Trial Design Using Retroviral Vectors for Long-Term Gene Correction in Hematopoietic Stem Cell Gene Therapy
Corrigan-Curay J; Cohen-Haguenauer O; O'Reilly M; Ross SR; Fan H; Rosenberg N; Somia N; King N; Friedmann T; Dunbar C; Aiuti A; Naldini L; Baum C; von Kalle C; Kiem H-P; Montini E; Bushman F; Sorrentino BP; Carrondo M; Malech H; Gahrton G; Shapiro R; Wolff L; Rosenthal E; Jambou R; Zaia J; Kohn DB
Meeting abstract: BLOOD. 2011;118(21):877
Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT
Morris C; Iacobelli S; Gahrton G; Garderet L; Drake M; van Biezen A; Mohty M; Blaise D; Poire X; Kersten MJ; Milpied N-J; Lenhoff S; Russell NH; Finke J; de Witte TM
Review: JOURNAL OF INTERNAL MEDICINE. 2011;269(2):137-147
Clinical impact of chromosomal aberrations in multiple myeloma
Nahi H; Sutlu T; Jansson M; Alici E; Gahrton G
Review: CURRENT GENE THERAPY. 2010;10(6):414-422
Relevance of an Academic GMP Pan-European Vector Infra-Structure (PEVI)
Cohen-Haguenauer O; Creff N; Cruz P; Tunc C; Aiuti A; Baum C; Bosch F; Blomberg P; Cichutek K; Collins M; Danos O; Dehaut F; Federspiel M; Galun E; Garritsen H; Hauser H; Hildebrandt M; Klatzmann D; Merten OW; Montini E; O'Brien T; Panet A; Rasooly L; Scherman D; Schmidt M; Schweizer M; Tiberghien P; Vandendriessche T; Ziehr H; Yla-Herttuala S; von Kalle C; Gahrton G; Carrondo M
Review: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(29):4521-4530
International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple Myeloma
Lokhorst H; Einsele H; Vesole D; Bruno B; Miguel JS; Perez-Simon JA; Kroger N; Moreau P; Gahrton G; Gasparetto C; Giralt S; Bensinger W
Review: LEUKEMIA. 2010;24(10):1700-1712
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Terpos E; Dimopoulos MA; Sezer O; Roodman D; Abildgaard N; Vescio R; Tosi P; Garcia-Sanz R; Davies F; Chanan-Khan A; Palumbo A; Sonneveld P; Drake MT; Harousseau J-L; Anderson KC; Durie BGM; International Myeloma Working Group
Review: EUROPEAN JOURNAL OF HAEMATOLOGY. 2010;85(4):279-289
Progress in allogeneic transplantation for multiple myeloma
Gahrton G
Review: LEUKEMIA. 2010;24(6):1121-1127
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Kyle RA; Durie BGM; Rajkumar SV; Landgren O; Blade J; Merlini G; Kröger N; Einsele H; Vesole DH; Dimopoulos M; San Miguel J; Avet-Loiseau H; Hajek R; Chen WM; Anderson KC; Ludwig H; Sonneveld P; Pavlovsky S; Palumbo A; Richardson PG; Barlogie B; Greipp P; Vescio R; Turesson I; Westin J; Boccadoro M; International Myeloma Working Group
Meeting abstract: BLOOD. 2009;114(22):27
Tandem Autologous(ASCT)/Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT
Gahrton G; Bjorkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D
Review: LEUKEMIA. 2009;23(10):1716-1730
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
Palumbo A; Sezer O; Kyle R; Miguel JS; Orlowski RZ; Moreau P; Niesvizky R; Morgan G; Comenzo R; Sonneveld P; Kumar S; Hajek R; Giralt S; Bringhen S; Anderson KC; Richardson PG; Cavo M; Davies F; Bladé J; Einsele H; Dimopoulos MA; Spencer A; Dispenzieri A; Reiman T; Shimizu K; Lee JH; Attal M; Boccadoro M; Mateos M; Chen W; Ludwig H; Joshua D; Chim J; Hungria V; Turesson I; Durie BGM; Lonial S; IMWG
Review: LEUKEMIA. 2009;23(9):1545-1556
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Dimopoulos M; Terpos E; Comenzo RL; Tosi P; Beksac M; Sezer O; Siegel D; Lokhorst H; Kumar S; Rajkumar SV; Niesvizky R; Moulopoulos LA; Durie BGM; IMWG
Other: JOURNAL OF INTERNAL MEDICINE. 2009;265(5):618-619
Professor Lars Erik Bottiger, in memoriam (1924-2009)
de Faire U; Fagrell B; Holm G; Gahrton G; Hallberg L
Review: LEUKEMIA. 2009;23(2):215-224
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BGM; International Myeloma Working Group
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2009;144(2):266-268
The prognostic significance of 8p21 deletion in multiple myeloma
Sutlu T; Alici E; Jansson M; Wallblom A; Dilber MS; Gahrton G; Nahi H
Editorial comment: HAEMATOLOGICA. 2008;93(9):1295-1300
Allogeneic transplantation in multiple myeloma
Gahrton G; Bjorkstrand B
Editorial comment: LEUKEMIA. 2008;22(8):1479-1484
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement.
Hussein MA; Vrionis FD; Allison R; Berenson J; Berven S; Erdem E; Giralt S; Jagannath S; Kyle RA; LeGrand S; Pflugmacher R; Raje N; Rajkumar SV; Randall RL; Roodman D; Siegel D; Vescio R; Zonder J; Durie BGM; International Myeloma Working Group
Meeting abstract: BLOOD REVIEWS. 2007;21:S10-S12
Stem cell transplantation in multiple myeloma
Gahrton G
Corrigendum: LEUKEMIA. 2007;21(5):1134
International uniform response criteria for multiple myeloma (vol 20, pg 1467, 2006)
Durie BGM; Harousseau J-L; Miguel JS; Blade J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV
Corrigendum: LEUKEMIA. 2006;20(12):2220
International uniform response criteria for multiple myeloma (vol 20, pg 1467, 2006)
Durie BGM; Harousseau J-L; Miguel JS; Blade J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV
Published conference paper: HEMATOLOGY. 2005;10:127-128
Role of stem cell transplantation in myeloma
Gahrton G; Iacobelli S; Björkstrand B; Bourhis J; Corradini P; Crawley C; Morris C; Niederwieser D
Meeting abstract: BLOOD. 2004;104(11):264A
Long term follow-up shows no clinical benefit for CD34⁺ selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma:: An EBMT phase III randomized study.
Bourhis JH; Bouko Y; Koscielny S; Greinix H; Derigs G; Salles G; Feremans W; Bakkus M; Apperley J; Samson D; Bjorkstrand B; Niederwieser D; Gahrton G; Pico JL; Goldschmidt H
Meeting abstract: BLOOD. 2004;104(11):430A
Disruption of the HEXB/ENC-1 antisense gene and identification of elevated ENC-1 expression in patients with Hairy Cell Leukemia
Lerner M; Hammarsund M; Sangfelt O; Zhu CY; Merup M; Jansson M; Gahrton G; Kluin-Nelemans H; Einhorn S; Grander D; Corcoran M
Editorial comment: LANCET. 2004;364(9446):1648-1649
New therapeutic targets in multiple myeloma
Gahrton G
Published conference paper: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2002;76 Suppl 1:384-385
Goals and activities of the WMDA. World Marrow Donor Association.
Gahrton G
Review: JOURNAL OF INTERNAL MEDICINE. 2001;249(4):359-367
Suicide gene therapy: possible applications in haematopoietic disorders
Dilber MS; Gahrton G
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2001;249(4):327-328
Haematopoietic cell gene therapy - Introduction
Gahrton G
Review: JOURNAL OF INTERNAL MEDICINE. 2000;248(3):185-201
Progress in haematopoietic stem cell transplantation for multiple myeloma
Gahrton G; Björkstrand B
Review: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 1999;30(2):173-180
High-dose treatment of multiple myeloma
Gahrton G; Björkstrand B
Editorial comment: LANCET. 1999;353(9147):85-86
Treatment of multiple myeloma
Gahrton G
Published conference paper: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 1998;451:493-497
Gene marking and gene therapy in multiple myeloma
Gahrton G; Björkstrand B; Dilber MS; Sundman-Engberg B; Ljungman P; Smith CIE
Editorial comment: ANNALS OF ONCOLOGY. 1997;8(3):219-221
Bone marrow and peripheral blood stem cell transplantation in multiple myeloma
Gahrton G
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 1997;242:U2
International Society of Haematology (European and African Division) XIV Meeting - 30 August 4 September 1997 Stockholm, Sweden - Education Programme - President's message
Gahrton G
Letter: LANCET. 1996;348(9023):346
Graft-versus-myeloma effect
Aschan J; Lonnqvist B; Ringden O; Kumlien G; Gahrton G
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;17:S63-S64
Intensive treatment in order to minimize the Ph-positive clone in CML
Simonsson B; Oberg G; Bjoreman M; Bjorkholm M; Carneskog J; Gahrton G; Hast R; Karl H; LanngNielsen J; Lofvenberg E; Malm C; Turesson I; Uden AM; Vilen L; WeisBjerrum O
Review: BONE MARROW TRANSPLANTATION. 1996;17(1):13-18
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Review: WIENER MEDIZINISCHE WOCHENSCHRIFT. 1995;145(2-3):52-54
Autologous stem-cell transplantation in multiple myeloma.
Gahrton G
Visa fler

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI